WBP1P2

Across TCGA pan-cancer cohorts, WBP1P2 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated WBP1P2 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher WBP1P2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated WBP1P2 expression acts as an unfavorable survival marker, although some lineages such as KIRC and BLCA show a favorable association.

KIRC, BLCA, and LIHC are the cancer types where WBP1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.718	0.527	<.001	96	view →
BLCA	OS	Quartile	All	0.494	0.324	.001	83	view →
LIHC	OS	Median	II,III,IV	0.462	0.741	<.001	54	view →
STAD	OS	Quartile	All	0.466	0.664	.003	44	view →
PAAD	OS	Median	All	0.394	0.581	.002	38	view →
SKCM	OS	Tertile	III,IV	0.518	0.195	.001	35	view →
LAML	DFS	Median	All	0.350	0.550	.002	34	view →
KICH	DFS	Tertile	All	0.582	1.000	.003	30	view →
UCEC	OS	Quartile	All	0.806	0.904	.013	30	view →
THCA	OS	Tertile	II,III,IV	0.337	1.000	.010	16	view →
UCS	OS	Tertile	IV	0.226	0.675	.036	12	view →
KIRP	OS	Quartile	All	1.000	0.916	.008	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

WBP1P2–KIRC (DFS)

Open the KIRC breakdown →